DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Biodel Inc. (BIOD)
« Back to company indexBIOD Chatter Timeline
Stock Ticker for BIOD
Most Active Tweeters for BIOD
| User | Tweets |
|---|---|
| @Allstocknews | 2 |
Recent Tweets for BIOD
 |
@Allstocknews $BIOD Albireo Presents Data on A4250 in Children with Biliary Atresia and Alagille Syndrome at The Internatio From our Stock News Alerts App April 13th 2019, 7:04am |
|
@Allstocknews $BIOD Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAF From our Stock News Alerts App April 11th 2019, 7:04am |
 |
@Stock_News_Now $BIOD: New SEC Filing for BIOD: Form 8-K (No. 0001104659-19-019486): https://t.co/8nDFGVSqgg April 3rd 2019, 7:04am |
 |
@confcalltran Entry into a Material Definitive https://t.co/vASgzAYXiw $BIOD April 3rd 2019, 6:04am |
|
@Allstocknews $BIOD Albireo to Present at Investor Conferences in April From our Stock News Alerts App April 1st 2019, 7:04am |
|
@Allstocknews $BIOD New Form 3 for Albireo Pharma Inc From our Stock News Alerts App March 27th 2019, 5:03pm |
|
@Allstocknews $BIOD Albireo to Present Clinical Data on A4250 in Alagille Syndrome and Biliary Atresia at The International From our Stock News Alerts App March 27th 2019, 9:03am |
|
@Allstocknews $BIOD Stock Quote Notification for Albireo Pharma Inc From our Stock News Alerts App March 26th 2019, 6:03pm |
|
@Allstocknews $BIOD Albireo Expands Executive Leadership Team with Appointment of Pamela Stephenson as Chief Commercial Of From our Stock News Alerts App March 21st 2019, 8:03am |
|
@Stock_News_Now $BIOD: New SEC Filing for BIOD: Form SC 13D/A (No. 0001140361-19-004842): https://t.co/Aak1bVLzQT March 13th 2019, 3:03pm |
|
@Allstocknews $BIOD New Form SC 13D/A for Albireo Pharma Inc From our Stock News Alerts App March 13th 2019, 2:03pm |
|
@Allstocknews $BIOD Albireo Reports Year-End 2018 Financial Results and Provides Pipeline Update From our Stock News Alerts App March 7th 2019, 7:03am |
|
@Stock_News_Now $BIOD: New SEC Filing for BIOD: Form 8-K (No. 0001104659-19-013162): https://t.co/hh8mCHVLdI March 7th 2019, 6:03am |
|
@Allstocknews $BIOD New Form 8-K for Albireo Pharma Inc From our Stock News Alerts App March 6th 2019, 5:03pm |
|
@Allstocknews $BIOD New Form S-3 for Albireo Pharma Inc From our Stock News Alerts App March 6th 2019, 5:03pm |
|
@Allstocknews $BIOD New Form 10-K for Albireo Pharma Inc From our Stock News Alerts App March 6th 2019, 5:03pm |
|
@Allstocknews $BIOD Albireo to Present at Cowen and Company 39th Annual Health Care Conference From our Stock News Alerts App March 4th 2019, 8:03am |
|
@Allstocknews $BIOD Albireo Recognizes Rare Disease Day and Highlights Urgent Need to Support Families Affected by Progress From our Stock News Alerts App February 28th 2019, 8:02am |
|
@Allstocknews $BIOD Albireo to Report Year-End 2018 Financial Results and Host Conference Call and Webcast on March 7, 2019 From our Stock News Alerts App February 27th 2019, 8:02am |
 |
@BoardCentral $BIOD "Biodel / Albireo Reverse Merger Complete! New Symbol ALBO" on ADFN InvestorsHub message boards: https://t.co/R5f0mKnZcZ February 16th 2019, 10:02am |
|
@Allstocknews $BIOD New Form SC 13G/A for Albireo Pharma Inc From our Stock News Alerts App February 14th 2019, 5:02pm |
|
@confcalltran ArrowMark Colorado Holdings, LLC just provided an update on share ownership of Biodel Inc. https://t.co/6UPMysHlyn $BIOD February 14th 2019, 9:02am |
|
@Allstocknews $BIOD New Form SC 13G for Albireo Pharma Inc From our Stock News Alerts App February 14th 2019, 8:02am |
|
@Stock_News_Now $BIOD: New SEC Filing for BIOD: Form SC 13G (No. 0001172661-19-000553): https://t.co/GAp7xzcpfA February 14th 2019, 7:02am |
|
@Stock_News_Now $BIOD: New SEC Filing for BIOD: Form SC 13G/A (No. 0001193125-19-037298): https://t.co/zbmdOxXEeN February 13th 2019, 11:02am |
|
@Allstocknews $BIOD New Form 4 for Albireo Pharma Inc From our Stock News Alerts App January 24th 2019, 6:01pm |
|
@Allstocknews $BIOD Albireo Granted Orphan Drug Designation by FDA For Lead Product Candidate A4250 for Treatment of Biliar From our Stock News Alerts App January 22nd 2019, 8:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.